Applications of fluorescence in the characterization of the ligand-binding domain and activation of the cholecystokinin receptor

被引:4
|
作者
Harikumar, KG [1 ]
Miller, LJ [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA
来源
PHARMACOLOGY & TOXICOLOGY | 2002年 / 91卷 / 06期
关键词
D O I
10.1034/j.1600-0773.2002.910604.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Fluorescence techniques can be applied to guanine nucleotide-binding protein-coupled receptors to gain insights into the environment and molecular motion of a fluorophore that is either incorporated into a ligand or more directly into a specific site within the receptor. Fluorescence studies can provide insight into the environment of that indicator. By situating the same indicator into an analogous position in both agonist and antagonist ligands. comparisons can provide insights into differences between active and inactive states of the receptor. These types of studies haw been performed for the cholecystokinin receptor and show that receptor activation by agonist occupation is associated with a movement of the CCK-like ligand out of a protected environment and into a more accessible hydrophilic milieu.
引用
收藏
页码:286 / 289
页数:4
相关论文
共 50 条
  • [41] Production and characterization of a recombinant ligand-binding domain of the human low-density lipoprotein receptor
    Golubkov, VI
    Mandelshtam, MY
    Runova, OL
    Gaitskhoki, VS
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 1997, 123 (02) : 159 - 162
  • [42] The androgen receptor ligand-binding domain stabilizes DNA binding in living cells
    Farla, P
    Hersmus, R
    Geverts, B
    Mari, PO
    Nigg, AL
    Dubbink, HJ
    Trapman, J
    Houtsmuller, AB
    JOURNAL OF STRUCTURAL BIOLOGY, 2004, 147 (01) : 50 - 61
  • [43] PURIFICATION, FUNCTIONAL-CHARACTERIZATION, AND CRYSTALLIZATION OF THE LIGAND-BINDING DOMAIN OF THE RETINOID-X RECEPTOR
    BOURGUET, W
    RUFF, M
    BONNIER, D
    GRANGER, F
    BOEGLIN, M
    CHAMBON, P
    MORAS, D
    GRONEMEYER, H
    PROTEIN EXPRESSION AND PURIFICATION, 1995, 6 (05) : 604 - 608
  • [44] Role of D-serine Binding to the NMDA Receptor Ligand-Binding Domain
    Yovanno, Remy A.
    Lau, Albert Y.
    BIOPHYSICAL JOURNAL, 2021, 120 (03) : 192A - 192A
  • [45] Mass spectrometric characterization of the human androgen receptor ligand-binding domain expressed in Escherichia coli
    Zhu, ZX
    Becklin, RR
    Desiderio, DM
    Dalton, JT
    BIOCHEMISTRY, 2001, 40 (36) : 10756 - 10763
  • [46] THE MOLECULAR-BASIS OF LIGAND-BINDING TO THE HUMAN CHOLECYSTOKININ-B GASTRIN RECEPTOR
    KOPIN, AS
    BEINBORN, M
    MCBRIDE, EW
    QUINN, SM
    GASTROENTEROLOGY, 1994, 106 (04) : A820 - A820
  • [47] Ligand control of interaction in vivo between ecdysteroid receptor and ultraspiracle ligand-binding domain
    Bergman, T
    Henrich, VC
    Schlattner, U
    Lezzi, M
    BIOCHEMICAL JOURNAL, 2004, 378 : 779 - 784
  • [48] Analysis of the ligand-binding domain of macrophage colony-stimulating receptor
    LUO Shouqing
    2. State Key Laboratory of Medicial Molecular Biology
    ChineseScienceBulletin, 2000, (13) : 1191 - 1195
  • [49] THE LIGAND-BINDING DOMAIN OF THE NICOTINIC ACETYLCHOLINE-RECEPTOR - IMMUNOLOGICAL ANALYSIS
    KACHALSKY, SG
    ALADJEM, M
    BARCHAN, D
    FUCHS, S
    FEBS LETTERS, 1993, 318 (03) : 264 - 268
  • [50] CHARACTERIZATION OF THE LIGAND-BINDING REGION IN THE HUMAN FORMYL PEPTIDE RECEPTOR
    RADEL, SJ
    DENARDIN, E
    FASEB JOURNAL, 1994, 8 (04): : A502 - A502